U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Aqueous plant extract having antiviral activity

Patent 5639460 Issued on June 17, 1997. Estimated Expiration Date: Icon_subject June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Re31836

Treatment for herpes virus
Patent #: 4285934
Issued on: 08/25/1981
Inventor: Tinnell

Angled tip applicator
Patent #: 4887924
Issued on: 12/19/1989
Inventor: Green

Method of treating defective T-lymphocyte function with rutin or troxerutin in combination with γ-linolenic acid or dihomo-γ-linolenic acid
Patent #: 4888326
Issued on: 12/19/1989
Inventor: Horrobin

Method of reducing porphyrin toxicity using fatty acids
Patent #: 4996233
Issued on: 02/26/1991
Inventor: Horrobin

Topical pharmaceutical compositions
Patent #: 5145686
Issued on: 09/08/1992
Inventor: Horrobin, et al.

Anti-virals
Patent #: 5216142
Issued on: 06/01/1993
Inventor: Horrobin, et al.

Lithium salt-containing pharmaceutical compositions
Patent #: 5252333
Issued on: 10/12/1993
Inventor: Horrobin

Anti-virals
Patent #: 5276020
Issued on: 01/04/1994
Inventor: Horrobin, et al.

Fatty acid compositions
Patent #: 5328691
Issued on: 07/12/1994
Inventor: Horrobin, et al.

More ...

Inventor

Application

No. 479602 filed on 06/07/1995

US Classes:

424/778, Containing or obtained from a flower or blossom (aka flos)424/725, PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)514/934Virus

Examiners

Primary: Rollins, John W.

Attorney, Agent or Firm

International Class

A61K 035/78

Abstract

An aqueous extract of Oenothera caespitosa having antiviral activity. Compositions containing such an extract are especially effective in topically treating herpes simplex lesions. Methods of making and using the extract are also disclosed. Topically applied compositions relieve pain and promote healing of lesions caused by the herpes simplex virus, varicella virus, and Epstein-Barr virus. The composition may also reduce the recurrence of herpes simplex lesions and act as a prophylactic agent by interrupting the spread of the virus and subsequent vesicle and lesion formation.

Other References

  • George Pettit, et al., Chem. Abst. 79:123648, "Antineoplastic agents.31. Oenothera caespitosa". 1973
  • Zinsmeister et al., "Flavonol Glycosides in South American Species Of Oenothera Sect. Oenothera", Phytochemistry, 1977, vol. 16, p. 497
  • G. Neumann et al., "Organ-and-Tissue-specific Biosynthesis of Flavonoids in Seedlings of Oenothera odorate (Onagraceae)", Bot. Acta 107, pp. 95-102, 1994
  • Petit et al., "Antineoplastic Agents 31. Oenothera caespitosa" Lloydia, pp. 202-203 (1973
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?